Calton & Associates, Inc. Amicus Therapeutics, Inc. Transaction History

Calton & Associates, Inc.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	BUY	$9.97 - $14.52 $99,809 - $145,359	10,011 New	10,011 $142,000
Q2 2023 Jul 24, 2023	SELL	$10.72 - $13.3 $4,727 - $5,865	-441 Reduced 3.88%	10,923 $137,000
Q1 2023 Apr 19, 2023	SELL	$10.91 - $13.54 $11,160 - $13,851	-1,023 Reduced 8.26%	11,364 $126,000
Q4 2022 Jan 18, 2023	SELL	$9.89 - $12.7 $395 - $508	-40 Reduced 0.32%	12,387 $0
Q3 2022 Oct 31, 2022	SELL	$9.82 - $12.75 $40,635 - $52,759	-4,138 Reduced 24.98%	12,427 $129,000
Q2 2022 Jul 12, 2022	SELL	$6.23 - $11.12 $5,949 - $10,619	-955 Reduced 5.45%	16,565 $177,000
Q1 2022 Apr 12, 2022	BUY	$7.89 - $12.48 $138,232 - $218,649	17,520 New	17,520 $165,000
Q1 2021 May 03, 2021	SELL	$9.2 - $23.86 $84,437 - $218,987	-9,178 Closed	0 $0
Q4 2020 Jan 25, 2021	SELL	$13.47 - $24.89 $30,334 - $56,052	-2,252 Reduced 19.7%	9,178 $212,000
Q3 2020 Oct 30, 2020	SELL	$12.89 - $15.89 $15,377 - $18,956	-1,193 Reduced 9.45%	11,430 $161,000
Q2 2020 Aug 10, 2020	SELL	$8.86 - $15.69 $797 - $1,412	-90 Reduced 0.71%	12,623 $190,000
Q1 2020 Apr 30, 2020	BUY	$6.63 - $11.16 $10,979 - $18,480	1,656 Added 14.98%	12,713 $117,000
Q4 2019 Feb 03, 2020	BUY	$7.48 - $10.75 $3,081 - $4,429	412 Added 3.87%	11,057 $108,000
Q3 2019 Nov 07, 2019	BUY	$8.02 - $13.25 $85,372 - $141,046	10,645 New	10,645 $85,000

312

312M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.68B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Calton & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Calton & Associates, Inc. with notifications on news.